Rewalk Robotics (RWLK) Hits New 52-Week Low at $0.21

Share on StockTwits

Rewalk Robotics Ltd (NASDAQ:RWLK)’s share price reached a new 52-week low during mid-day trading on Thursday . The stock traded as low as $0.21 and last traded at $0.21, with a volume of 367821 shares trading hands. The stock had previously closed at $0.21.

RWLK has been the subject of several analyst reports. Oppenheimer set a $2.00 target price on shares of Rewalk Robotics and gave the company a “buy” rating in a research note on Friday, August 24th. Zacks Investment Research upgraded shares of Rewalk Robotics from a “hold” rating to a “buy” rating and set a $1.25 target price for the company in a research note on Thursday, August 30th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and three have issued a buy rating to the company. Rewalk Robotics currently has an average rating of “Hold” and an average price target of $1.85.

The company has a market cap of $7.55 million, a PE ratio of -0.20 and a beta of 0.60.

Rewalk Robotics (NASDAQ:RWLK) last posted its quarterly earnings data on Thursday, November 8th. The medical device company reported ($0.13) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.14) by $0.01. The company had revenue of $1.62 million during the quarter, compared to analysts’ expectations of $2.12 million. Rewalk Robotics had a negative net margin of 352.11% and a negative return on equity of 3,654.32%. As a group, equities research analysts predict that Rewalk Robotics Ltd will post -0.67 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This piece of content was first reported by Fairfield Current and is owned by of Fairfield Current. If you are viewing this piece of content on another website, it was illegally copied and reposted in violation of United States & international trademark & copyright law. The legal version of this piece of content can be accessed at

About Rewalk Robotics (NASDAQ:RWLK)

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes exoskeletons for wheelchair-bound individuals with mobility impairments or other medical conditions. The company offers ReWalk Personal for everyday use to paraplegic individuals at home and in their communities; and ReWalk Rehabilitation for exercise and therapy used in hospitals and rehabilitation centers in the United States and Europe.

Recommended Story: Cost of equity and a company’s balance sheet

Receive News & Ratings for Rewalk Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rewalk Robotics and related companies with's FREE daily email newsletter.

Leave a Reply